- ILMN has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $216.8 million.
- ILMN is up 2.4% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in ILMN with the Ticky from Trade-Ideas. See the FREE profile for ILMN NOW at Trade-Ideas More details on ILMN: Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. ILMN has a PE ratio of 118.8. Currently there are 9 analysts that rate Illumina a buy, no analysts rate it a sell, and 8 rate it a hold. The average volume for Illumina has been 1.7 million shares per day over the past 30 days. Illumina has a market cap of $22.0 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.90 and a short float of 18.3% with 4.76 days to cover. Shares are up 59.4% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.